Celcuity INC 8-K filings

NASDAQ
Celcuity Inc. stockholders approved an increase in shares allocated for issuance under the 2017 Stock Incentive Plan and an increase in the number of incentive award shares at the 2024 Annual Meeting.
NASDAQ
Celcuity Inc. has amended its loan agreement to extend the deadline for drawing down a $10 million term loan to June 1, 2024.
NASDAQ
Celcuity Inc. announced its fourth quarter and full year 2023 financial results, highlighting increased spending on clinical trials and securing funding to support operations into the first half of 2026.